Balmes Transplantation
PrivateCompany Overview
Balmes Transplantation was a pharmaceutical company that developed drug candidates for reducing ischemia-reperfusion injuries in organ transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Balmes Transplantation Comparables
Compare Balmes Transplantation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| cellvie | 82% | |
| Morningside | 70% | |
| Ischemix, Inc. | 69% |
Balmes Transplantation Funding Rounds
Historical fundraising activity
Balmes Transplantation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Balmes Transplantation's valuation, stock price, and market status.
Is Balmes Transplantation a public or private company?
Balmes Transplantation is a private company.
What is the current stock price of Balmes Transplantation?
Balmes Transplantation is a private company with no public stock price. No recent secondary market data is available.
How much is Balmes Transplantation worth (valuation)?
Valuation information for Balmes Transplantation is not publicly available.
Can I buy Balmes Transplantation stock?
Balmes Transplantation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Balmes Transplantation's last funding round?
Funding round information for Balmes Transplantation is not publicly available.
Who are the main investors in Balmes Transplantation?
Investor information for Balmes Transplantation is not publicly disclosed.
Will Balmes Transplantation IPO soon?
No public IPO plans have been announced for Balmes Transplantation.
How can I track Balmes Transplantation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Balmes Transplantation's secondary market activity and sign up for updates.